In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

44th EWGCCE - abstract submission rules

To present your abstract at the 44th EWGCCE, please submit via the online platform only. Abstract sent in any other form will not be accepted.

Options available

  • Full abstract (standard submission): abstracts will be considered for oral presentations or poster presentations. Abstract submitters may qualify for a travel grant or poster award.
  • Poster Title only: titles will apply for poster presentation only. Title submitters may not qualify for a travel grant or poster award.

General information


3 November 2019: Opening of the online submission services

21 February 2020: Abstract submission deadline

17 April 2020: Poster title submission deadline

Changes and corrections

Once submitted, it is not possible to make any corrections to the abstract content or information (such as Presenter details, topic, authors list etc...). The ESC is not authorized to make changes to a submission. In order to correct your abstract you must withdraw it and submit a new corrected version prior to the deadline (See below for withdrawal procedure). Note that, such replacement of your abstract is not possible after the deadline. In the case of errors in your abstract discovered after the deadline, you may indicate the correction during the presentation at the congress. However, changes will not be included in the publications. If accepted, your abstract will be published as submitted.

If you want to withdraw an abstract already submitted, please notify us as quickly as possible at stating the title of the abstract to be withdrawn.

Note that, withdrawals are still accepted after the submission deadline but abstracts may still appear in publications.

All abstract withdrawal requests must be received in writing (via e-mail) by December 2019 to avoid publications.

Step 1: Abstract Information


Maximum 200 characters typed in lower-case letters, except for abbreviations and study names. Please be careful that your title might be truncated if you copy and paste it into the field. Do not include authors, institutions, city names, trademarks and abbreviations in the title.



You must select among the available options

  • Full abstract (standard submission): abstracts will be considered for oral presentations or poster presentations. Abstract submitters may qualify for a travel grant or poster award.
  • Title only: titles will apply for Poster Presentation only. Title submitters may not qualify for a travel grant or poster award.

Eligibility Criteria

To submit an abstract / title, you must be a member of the ESC Working Group on Cardiac Cellular Electrophysiology. Membership is free.

Become a member

Funding Acknowledgements

All sources of financial support (including governmental grants) for this research should be listed under this heading. All grant funding agency abbreviations should be spelled out.

Step 2: Abstract authors and institutions

Your abstract must list at least 1 author in order to be submitted.

Authors list

Please note that the first author should be the abstract Presenter by default.

Nevertheless, it can be modified by notifying by email In all cases, the Presenter must be part of the authors list included in the submitted abstract and be able to explain his/her role in the research during presentation.

You may enter up to 10 authors in the authors list including the Presenter.

The names of authors will be published as listed on the submission form. Please make sure you have enter the full list of authors and that the information given for each author is correct, as no changes will be possible after the abstract is submitted (see paragraph on changes and corrections above).

The authors’ order and details (names, cities, country codes) will be published as entered by the submitter.

The submitter certifies and warranties to the ESC that he/she has permission from all persons he/she enters as co-authors to be listed in this abstract and that they are aware that their names will appear in all publications.

If none of the authors are able to present the abstract during the congress, the abstract should be withdrawn. If not, it will be considered as no-show and the Congress Programme Committee can then decide not to consider an abstract submitted by the same author the following year.


This is a mandatory step.

You will be requested to select your institution when you create the presenter and the authors.

Step 3: Abstract Content

All abstracts must be submitted (and will be presented) in English using UK English spelling with accurate grammar and spelling suitable for publication. If in doubt, please arrange for the review of your abstract by a native English speaker, by a university scientific publications office (or other similar facility) prior to submission.

Abstracts must contain original material neither published nor presented elsewhere prior to 44 EWGCCE (in print or electronically).

Abstract submitted on animal studies: Study must follow the "Principles of laboratory animal care" (NIH Publication no. 85-23 revised 1985) and according to the national law if applicable.

We recommend you structure your abstract using the following headings:

  • Background/Introduction
  • Purpose
  • Methods
  • Results
  • Conclusion(s)

There is not a specific maximum of words, but we recommend 2500 caracters.

Abstract Tables & pictures

You may include tables & pictures in your abstract, provided you own the copyright on all elements.

Important: As the grading and selection process is blinded, the title and body text must not contain identifying features, ie information such as

  • Names (authors or other)
  • Names of institute (hospitals, medical schools, clinics…
  • Cities

Also not authorised

  • Trademarks. Use generic drug names. The use of commercial drug names, brands and registered trademarks is strictly prohibited. Drugs should be referred to by the active substance or pharmacological designation
  • Company names and location
  • Web sites and email addresses

Failure to comply with the above requirements will/may lead to automatic rejection of the submission or this information may be deleted by the abstract services and some rephrasing may occur.

Furthermore, the Abstract Review Committee (graders) is required to identify abstracts pertaining to commercial promotion of a proprietary product, to notify the selection committee.

Do not include grant acknowledgements in the abstract content. Use the appropriate field.

Do not cite keywords or references in the abstract, as they are not allowed and will be deleted.

Do not include copyright or trademark symbols.

Limit use of acronyms and abbreviations. Define at first use with acronym or abbreviation in parentheses.

Please note that any medical research involving human subjects must conform to the principles of the Declaration of Helsinki of the World Medical Association. We remind you that patient’s photo should be avoided and the patient must never be identifiable in your presentation.

Step 4: Abstract Preview and submission

Proofread abstracts carefully to avoid errors before upload, check spelling and grammar. The abstract will be reviewed as it has been submitted – NO EXCEPTIONS.

Do not forget to click on the Submit button to validate your abstract submission. After having submitted your abstract, you will receive an immediate automatic confirmation by email (please make sure to state your correct email address!).

There is no limit to the number of abstracts an author/individual may submit, but the same research cannot be submitted twice, even under a different topic/category or with a different title. If you submit two abstracts with the same content, the abstract submission service will automatically keep the most recent abstract submitted and withdraw the other. Note that duplicate draft abstracts will not be deleted.

If you have difficulties in submitting your abstracts or if you need any further information, please contact the Working Groups team at

Abstract Grading/Results

All abstracts will be blinded for review by members of the Abstract Review Committee (graders). Each grader is selected by the ESC Working Group on Cardiac Cellular Electrophysiology to review abstracts in their category that best fits their expertise.

Our intent is to be most inclusive of the quality science received without compromising scientific integrity.

The Abstract Review Committee (graders) is required to identify abstracts pertaining to commercial promotion of a proprietary product, to notify the selection committee.

Abstracts submitted for consideration must be an original idea, concept, or an improvement or revision of a previous idea. Submissions are peer-reviewed for scientific content, logical presentation, and current interest of the topic to the scientific community.

The final selection will be made by the ESC Working Group on Cardiac Cellular Electrophysiology who will determine the format, day and time of presentation for each abstract.

Accepted abstracts will be scheduled either as oral presentations or Poster Presentations.

All presentations including question-and-answers will be conducted in English. Presenters are expected to be good English speakers.

All submitters will be notified by e-mail by about the outcome (accepted or not accepted) of the review and selection process. Please ensure that the email provided is accurate as all correspondences will be sent via email.

If the abstract is accepted, instructions and guidelines concerning the abstract presentation will be provided online.

The same presenter cannot be assigned to more than 3 abstracts - co-authors should then be assigned as presenters.

All expenses (airfare, hotel, registration....) associated with the submission and presentation of an abstract, are under the responsibility of the presenter.

No-show Policy

Submission of an abstract constitutes a commitment by the author(s) to present if accepted. Failure to present and register for the 44 EWGCCE, if not justified (abstract withdrawn), will be identified as “no-show” and will jeopardize future acceptance of abstracts.

Publication of abstracts

Accepted abstracts will be published in the Final Programme. 

There will not be an abstract book.

Affirmation of Originality and Copyrights transfer statement

By submitting your work to the ESC, you consent to have authors’ names, affiliation and biographical material used in connection with the publication of your work.
Author(s) represents and warrants that he/she/they is/are sole author(s) of the work, that all authors have participated in and agree with the content and conclusions of the work, and that the work is original and does not infringe upon any copyright, proprietary, or personal right of any third party.

The submitter hereby affirms that the work submitted is original, except for extracts from copyrighted works fully authorised by the copyright holders, and that all statements declared as facts are based on thorough examination and investigation for accurateness.

Submitted abstracts should not have been published in any other journals and/or online publications nor presented at any previous international congress. However, former presentation at national meetings and/or non cardiovascular specialists meetings does not disqualify.

A submitter, presenter or co-author submitting or presenting published work will lead to:
Withdrawal of their presentation from the Press Conference and/or Scientific Session
Prohibition of submitting abstracts to any ESC congresses for one year
Submitted abstracts must report new information not previously published or presented at a national or international scientific meeting prior to the Congress. Note that abstracts previously presented at meetings will not be accepted unless there is a substantial update of data.
Identified duplicates will be retracted from all related ESC publications.
The content belongs to the author(s). However if the abstract is accepted the submitter agrees, on behalf of all co-authors, to transfer and assign to the ESC the rights to reformat, publish, reproduce, distribute and prepare derivative works such as press releases and/or educational products directly or with partners. This includes use in indexes or search databases in print, electronic (ex: ESC TV, Congress 365, SP&P), or other media.
Author(s) retain the right, after presentation at the Congress, to subsequently include the work in articles, books, or derivative works that he/she authors or edits, provided said use does not imply the endorsement of the ESC.

The submitter signs for all co-authors. He/she accepts responsibility for the present rules for submission and presentation on behalf of all co-authors.

Conflict of interest

The ESC Working Group on Cardiac Cellular Electrophysiology requests all presenters to display a slide at the beginning of their presentation (at the bottom of the poster for poster presentations) indicating disclosure information for themselves and all coauthors as applicable, or that they have nothing to disclose. Please state "None" if no conflicts exist.

This will allow the audience to take potential conflicts of interest into account when assessing the objectivity of the presentation.

A potential conflict of interest may arise from various relationships, past or present, such as employment, consultancy, investments and stock ownership, funding for research, family relationship, etc.

All potential conflicts of interest must be stated.

This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the article. Such relationships include, but are not limited to, employment by an industrial concern, ownership of stock, membership on a standing advisory council or committee, being on the board of directors, or being publicly associated with the company or its products. Other areas of real or perceived conflict of interest could include receiving honoraria or consulting fees or receiving grants or funds from such corporations or individuals representing such corporations.

Data Privacy

The information collected in Working Group on Cardiac Cellular Electrophysiology Annual Meeting form is subject to data processing to select oral and poster presenters at the 44th EWGCCE.

The recipients of the data are ESC Staff who process the forms as well as Working Group Nucleus Members for scientific review.

Data collected will be kept until the end of the congress

These data will be stored in Formstack

In accordance with the chapter 3 of the European Regulation 2016/679 with regards to data protection, you have the right to request from ESC, access to and rectification or erasure of your personal data or restriction of processing concerning your data or to object to processing as well as the right to data portability.

 For such, please contact (together with a proof of identity) :

Data Privacy
European Society of Cardiology
Les Templiers
2035 Route des Colles
CS 80179 Biot

Or by email to

You have the right to lodge a complaint with a supervisory authority, and for information, ESC has appointed a Data Protection Officer that you can reach at

Applicable law

All the rules pertaining to the present submission are governed by and construed in accordance with the laws of France without regard to any conflicts of laws principles thereof that would require the application of the law of any other jurisdiction. Any disputes arising in relation hereto shall be submitted to the exclusive jurisdiction of the French Tribunal de Grande Instance located in Grasse, France.